Huangpu biopharmaceutical conference boosts industry development

The inaugural Guangzhou International Biopharmaceutical Industry Conference was held from May 25 to 27 in Guangzhou's Huangpu district. 

Nearly 1,000 attendees, including 10 scientists and representatives from renowned companies, gathered for the event. Additionally, 12 high-quality biopharmaceutical project contracts were signed at the event, driving the development of the biopharmaceutical industry. 

Huangpu district, as the core region for Guangzhou's biopharmaceutical industry, has attracted over 3,000 biopharmaceutical enterprises through the improvement of its industrial environment and policy support. From these improvements, the district has created a complete industrial chain.

The conference focused on key topics such as new infrastructure, medical research and development, cell therapies, and the commercialization of innovative medicines. All of which serve to further promote the growth of Guangzhou's biopharmaceutical industry.

The Inaugural Guangzhou International Biopharmaceutical Industry Conference is held in Huangpu.

A total of 12 high-quality biopharmaceutical project contracts are signed at the event in Huangpu.